Analystreport

Regulus Therapeutics Inc (NASDAQ: RGLS) was given a new $1.00 price target on by analysts at Wedbush. They now have a "hold" rating on the stock.

Regulus Therapeutics Inc.  (RGLS) 
Last regulus therapeutics inc. earnings: 3/12 04:37 pm Check Earnings Report
US:NASDAQ Investor Relations: regulusrx.com/investors